Target intelligence / Profile preview

tRNA methyltransferase 13 (TRMT13)

Target
TRMT13
Molecular classification
Enzyme, RNA-binding protein, Zinc finger protein
01

Overview

tRNA methyltransferase 13 (TRMT13) is a bifunctional enzyme involved in post-transcriptional modification of tRNA and gene regulation. In the cytoplasm, TRMT13 catalyzes the 2'-O-methylation of specific tRNAs, thereby fine-tuning protein synthesis by modulating translation[1][2]. Independently of its methyltransferase activity, nuclear TRMT13 binds directly to DNA at promoters via its CHHC zinc finger domain, acting as a transcriptional co-activator for genes controlling cell migration, particularly factors involved in epithelial–mesenchymal transition (EMT)[1][2]. Overexpression of TRMT13 correlates with poor prognosis in several cancers, highlighting its dual epitranscriptomic and transcriptional regulatory roles as well as its significance as a prognostic marker and a potential therapeutic target[1][2].

Other names
CCDC76tRNA:m(4)X modification enzyme TRM13 homologFLJ10287FLJ11219hTrmt13Coiled-coil domain-containing protein 76tRNA [Gm4] methyltransferasetRNA guanosine-2'-O-methyltransferase TRM13 homologtRNA methyltransferase 13 homolog
02

Biological functions

tRNA 2'-O-methylation (modification of tRNA)Regulation of protein translationTranscriptional co-activation (independent of catalytic activity)Promotion of epithelial–mesenchymal transition (EMT)Promotion of cell migration
03

Disease associations

Cancer (associated with metastasis and poor prognosis)Other (potentially involved in RNA and gene regulation, but primary disease role evidenced in cancer)
04

Biomarkers

Prognostic marker for poor outcomes in diverse cancer types

Beyond the preview

Go deeper on tRNA methyltransferase 13 (TRMT13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tRNA methyltransferase 13 (TRMT13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call